In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control.

This research paper explores the metabolic process of eight sedatives in horses and identifies metabolites that could assist in equine anti-doping efforts. The study was conducted in vitro to mitigate ethical and financial constraints.

Equine Metabolism of Sedatives

• The paper presents research on the equine metabolism of eight sedatives, none of which are licensed for use in horses in the UK. Understanding the metabolic process of these drugs in horses is crucial for enhancing equine anti-doping screening methods.
• The metabolic process of these drugs was previously unknown. The study provides information on target metabolites, which can facilitate the detection of illegal substance abuse in horse racing.

In Vitro Technique

• This research was conducted in vitro, meaning it was done outside of a living organism. This method was selected due to the ethical and financial issues associated with conducting such a test on multiple compounds within a living horse.
• Phase I metabolite information was obtained from equine liver S9 fraction. The S9 fraction is a subcellular mix obtained from liver tissue that contains enzymes crucial to the metabolism process, providing a reliable in vitro system for metabolic evaluation.

Identification of Metabolites

• The metabolites of each drug were identified using Liquid Chromatography-High Resolution Mass Spectrometric (LC-HRMS) analysis on an LTQ-Orbitrap, a high-end instrument that facilitates separation and identification of chemical substances based on their mass-to-charge ratio.
• Further structural information was garnered by Tandem Mass Spectrometry (MS/MS) analysis. This enabled researchers to hypothesize the structure of the most abundant in vitro metabolites.
• The most abundant metabolitesrelated to specific reactions such as hydroxylation, N-oxidation, deethylation, and demethylation. The precise positioning of the functional groups involved in these reactions would need further study to be fully understood.
• The metabolites identified in vitro are not definitive but constitute an educated prediction of those that might occur in vivo (within a living organism). Future discoveries of these drugs or their metabolites in horse urine samples could provide validation for these in vitro findings.